Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological Significance and Prognostic Value of DNA Methyltransferase 1, 3a, and 3b Expressions in Sporadic Epithelial Ovarian Cancer
Authors
Keywords
Ovarian cancer, DNA methylation, Benign tumors, Protein expression, Chi square tests, Histology, Menopause, Metastasis
Journal
PLoS One
Volume 7, Issue 6, Pages e40024
Publisher
Public Library of Science (PLoS)
Online
2012-06-30
DOI
10.1371/journal.pone.0040024
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- POTEH hypomethylation, a new epigenetic biomarker for glioma prognosis
- (2011) Xiaoping Liu et al. BRAIN RESEARCH
- Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas
- (2011) Ganeshkumar Rajendran et al. JOURNAL OF NEURO-ONCOLOGY
- Evaluation of serum LINE-1 hypomethylation as a prognostic marker for hepatocellular carcinoma
- (2011) Iman I. Ramzy et al. Arab Journal of Gastroenterology
- Overexpression of DNA Methyltransferases 1, 3a, and 3b Significantly Correlates With Retinoblastoma Tumorigenesis
- (2010) Yi Qu et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer
- (2010) Siqing Fu et al. CANCER
- A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer
- (2010) Fang Fang et al. CANCER
- Dysregulation of p53/Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung Cancer
- (2010) R.-K. Lin et al. CANCER RESEARCH
- DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas
- (2010) Khaled Amara et al. CANCER SCIENCE
- Increased Expression of DNA Methyltransferase-1 in Non-Neoplastic Epithelium Helps Predict Colorectal Neoplasia Risk in Ulcerative Colitis
- (2010) Shigehiko Fujii et al. DIGESTION
- DNA Methylation-mediated Down-regulation of DNA Methyltransferase-1 (DNMT1) Is Coincident with, but Not Essential for, Global Hypomethylation in Human Placenta
- (2010) Boris Novakovic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Utility of Gene Promoter Methylation in Prediction of Response to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC)
- (2009) Parvesh Chaudhry et al. CANCER INVESTIGATION
- Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
- (2009) R. Plummer et al. CLINICAL CANCER RESEARCH
- Minireview: Epigenetic Changes in Ovarian Cancer
- (2009) Curt Balch et al. ENDOCRINOLOGY
- Epigenetic therapies for chemoresensitization of epithelial ovarian cancer
- (2009) Daniela E. Matei et al. GYNECOLOGIC ONCOLOGY
- Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancer
- (2008) J Xing et al. BRITISH JOURNAL OF CANCER
- A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
- (2008) R. B. Klisovic et al. CLINICAL CANCER RESEARCH
- The Expression and Clinical Significance of DNA Methyltransferase Proteins in Human Gastric Cancer
- (2008) Wen-Jin Ding et al. DIGESTIVE DISEASES AND SCIENCES
- Down-regulation of CXCL12 mRNA expression by promoter hypermethylation and its association with metastatic progression in human breast carcinomas
- (2008) Wei Zhou et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started